PARP-2 deficiency affects the survival of CD4+CD8+ double-positive thymocytes. 2006

José Yélamos, and Yolanda Monreal, and Luis Saenz, and Enrique Aguado, and Valérie Schreiber, and Rubén Mota, and Teodomiro Fuente, and Alfredo Minguela, and Pascual Parrilla, and Gilbert de Murcia, and Elena Almarza, and Pedro Aparicio, and Josiane Ménissier-de Murcia
Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, University of Murcia, Murcia, Spain. jyelamos@um.es

Poly-(ADP-ribose) polymerase-2 (PARP-2) belongs to a large family of enzymes that synthesize and transfer ADP-ribose polymers to acceptor proteins, modifying their functional properties. PARP-2-deficient (Parp-2-/-) cells, similar to Parp-1-/- cells, are sensitive to both ionizing radiation and alkylating agents. Here we show that inactivation of mouse Parp-2, but not Parp-1, produced a two-fold reduction in CD4+CD8+ double-positive (DP) thymocytes associated with decreased DP cell survival. Microarray analyses revealed increased expression of the proapoptotic Bcl-2 family member Noxa in Parp-2-/- DP thymocytes compared to littermate controls. In addition, DP thymocytes from Parp-2-/- have a reduced expression of T-cell receptor (TCR)alpha and a skewed repertoire of TCRalpha toward the 5' Jalpha segments. Our results show that in the absence of PARP-2, the survival of DP thymocytes undergoing TCRalpha recombination is compromised despite normal amounts of Bcl-xL. These data suggest a novel role for PARP-2 as an important mediator of T-cell survival during thymopoiesis by preventing the activation of DNA damage-dependent apoptotic response during the multiple rounds of TCRalpha rearrangements preceding a positively selected TCR.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011065 Poly(ADP-ribose) Polymerases Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide (NAD) onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE. ADP-Ribosyltransferase (Polymerizing),Poly ADP Ribose Polymerase,Poly(ADP-Ribose) Synthase,Poly(ADP-ribose) Polymerase,PARP Polymerase,Poly ADP Ribose Transferase,Poly ADP-Ribose Synthase,Poly(ADP-Ribose) Transferase,Poly(ADPR) Polymerase,Poly(ADPribose) Polymerase,Poly ADP Ribose Synthase,Polymerase, PARP,Synthase, Poly ADP-Ribose
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D000071137 Poly (ADP-Ribose) Polymerase-1 A poly(ADP-ribose) polymerase that contains two ZINC FINGERS in its N-terminal DNA-binding region. It modifies NUCLEAR PROTEINS involved in chromatin architecture and BASE EXCISION REPAIR with POLY ADENOSINE DIPHOSPHATE RIBOSE. NAD+ ADP-ribosyltransferase-1,PARP-1 Protein,PARP1 Protein,Poly (ADP-Ribose) Synthase-1,NAD+ ADP ribosyltransferase 1,PARP 1 Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015329 Gene Rearrangement, T-Lymphocyte Ordered rearrangement of T-cell variable gene regions coding for the antigen receptors. Gene Rearrangement, T-Cell Antigen Receptor,T-Cell Gene Rearrangement,T-Lymphocyte Gene Rearrangement,Gene Rearrangement, T-Cell,Gene Rearrangement, T Cell,Gene Rearrangement, T Cell Antigen Receptor,Gene Rearrangement, T Lymphocyte,Gene Rearrangements, T-Cell,Gene Rearrangements, T-Lymphocyte,Rearrangement, T-Cell Gene,Rearrangement, T-Lymphocyte Gene,Rearrangements, T-Cell Gene,Rearrangements, T-Lymphocyte Gene,T Cell Gene Rearrangement,T Lymphocyte Gene Rearrangement,T-Cell Gene Rearrangements,T-Lymphocyte Gene Rearrangements
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D016158 Genes, p53 Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53. Genes, TP53,TP53 Genes,p53 Genes,Gene, TP53,Gene, p53,TP53 Gene,p53 Gene

Related Publications

José Yélamos, and Yolanda Monreal, and Luis Saenz, and Enrique Aguado, and Valérie Schreiber, and Rubén Mota, and Teodomiro Fuente, and Alfredo Minguela, and Pascual Parrilla, and Gilbert de Murcia, and Elena Almarza, and Pedro Aparicio, and Josiane Ménissier-de Murcia
January 2023, Frontiers in immunology,
José Yélamos, and Yolanda Monreal, and Luis Saenz, and Enrique Aguado, and Valérie Schreiber, and Rubén Mota, and Teodomiro Fuente, and Alfredo Minguela, and Pascual Parrilla, and Gilbert de Murcia, and Elena Almarza, and Pedro Aparicio, and Josiane Ménissier-de Murcia
March 2010, Journal of immunology (Baltimore, Md. : 1950),
José Yélamos, and Yolanda Monreal, and Luis Saenz, and Enrique Aguado, and Valérie Schreiber, and Rubén Mota, and Teodomiro Fuente, and Alfredo Minguela, and Pascual Parrilla, and Gilbert de Murcia, and Elena Almarza, and Pedro Aparicio, and Josiane Ménissier-de Murcia
July 2004, Journal of immunology (Baltimore, Md. : 1950),
José Yélamos, and Yolanda Monreal, and Luis Saenz, and Enrique Aguado, and Valérie Schreiber, and Rubén Mota, and Teodomiro Fuente, and Alfredo Minguela, and Pascual Parrilla, and Gilbert de Murcia, and Elena Almarza, and Pedro Aparicio, and Josiane Ménissier-de Murcia
April 2011, Journal of immunology (Baltimore, Md. : 1950),
José Yélamos, and Yolanda Monreal, and Luis Saenz, and Enrique Aguado, and Valérie Schreiber, and Rubén Mota, and Teodomiro Fuente, and Alfredo Minguela, and Pascual Parrilla, and Gilbert de Murcia, and Elena Almarza, and Pedro Aparicio, and Josiane Ménissier-de Murcia
August 2005, Journal of immunology (Baltimore, Md. : 1950),
José Yélamos, and Yolanda Monreal, and Luis Saenz, and Enrique Aguado, and Valérie Schreiber, and Rubén Mota, and Teodomiro Fuente, and Alfredo Minguela, and Pascual Parrilla, and Gilbert de Murcia, and Elena Almarza, and Pedro Aparicio, and Josiane Ménissier-de Murcia
September 2000, European journal of immunology,
José Yélamos, and Yolanda Monreal, and Luis Saenz, and Enrique Aguado, and Valérie Schreiber, and Rubén Mota, and Teodomiro Fuente, and Alfredo Minguela, and Pascual Parrilla, and Gilbert de Murcia, and Elena Almarza, and Pedro Aparicio, and Josiane Ménissier-de Murcia
September 1992, European journal of immunology,
José Yélamos, and Yolanda Monreal, and Luis Saenz, and Enrique Aguado, and Valérie Schreiber, and Rubén Mota, and Teodomiro Fuente, and Alfredo Minguela, and Pascual Parrilla, and Gilbert de Murcia, and Elena Almarza, and Pedro Aparicio, and Josiane Ménissier-de Murcia
November 1996, The Journal of experimental medicine,
José Yélamos, and Yolanda Monreal, and Luis Saenz, and Enrique Aguado, and Valérie Schreiber, and Rubén Mota, and Teodomiro Fuente, and Alfredo Minguela, and Pascual Parrilla, and Gilbert de Murcia, and Elena Almarza, and Pedro Aparicio, and Josiane Ménissier-de Murcia
November 2006, The Journal of pharmacology and experimental therapeutics,
José Yélamos, and Yolanda Monreal, and Luis Saenz, and Enrique Aguado, and Valérie Schreiber, and Rubén Mota, and Teodomiro Fuente, and Alfredo Minguela, and Pascual Parrilla, and Gilbert de Murcia, and Elena Almarza, and Pedro Aparicio, and Josiane Ménissier-de Murcia
December 1988, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!